Click to enlarge

GUIDELINES Pocketcards™ are multi-fold pocketcards containing society-endorsed, evidence-based treatment guidelines in a brief algorithmic format that is most preferred by practicing clinicians, quality managers, nurses, educators, and medical students.^{1, 2}

The Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk GUIDELINES Pocketcard™ is endorsed by The Endocrine Society and based on their latest guidelines. This practical quick-reference tool contains screening, risk assessment, diagnostics, a risk reduction algorithm, comprehensive drug and dosing information, patient monitoring, and treatment goals. The Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk GUIDELINES Pocketcard™ provides all that is needed to make accurate clinical decisions at the point of care including:

• Key Points
• Screening and Risk Assessment
• Diagnostic Criteria for the Metabolic Syndrome
• Treatment to Prevent CVD and T2DM
• Treatment Goals for Lipids
• Risk Reduction Algorithm
• Current Medication Tables with Brand and Generic Names
• Detailed Drug Information: Strengths, Formulations, Comments

Applications: point-of-care, education, QI interventions, clinical trials, medical reference, clinical research.

¹2007 PDR Physician Survey
²VA-HHS national guidelines attribute preference survey